American International Group, Inc. Lexicon Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 45,658 shares of LXRX stock, worth $73,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,658

Previous 46,049 0.85%

Holding current value

$73,052

Previous $70,000 55.71%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.3 - $3.58 $508 - $1,399	-391 Reduced 0.85%	45,658 $109,000
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.53 $186 - $284	-186 Reduced 0.4%	46,049 $70,000
Q3 2023 Nov 13, 2023	BUY	$1.06 - $2.33 $1,742 - $3,830	1,644 Added 3.69%	46,235 $50,000
Q2 2023 Aug 04, 2023	BUY	$2.15 - $3.49 $9,455 - $15,349	4,398 Added 10.94%	44,591 $102,000
Q1 2023 May 12, 2023	BUY	$1.99 - $2.68 $1,592 - $2,144	800 Added 2.03%	40,193 $97,000

Q4 2022 Feb 10, 2023	SELL	$1.8 - $2.56 $257 - $366	-143 Reduced 0.36%	39,393 $75,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $10,561 - $18,672	5,444 Added 15.97%	39,536 $95,000
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $871 - $1,788	-665 Reduced 1.91%	34,092 $63,000
Q1 2022 May 13, 2022	SELL	$1.95 - $3.89 $4,767 - $9,511	-2,445 Reduced 6.57%	34,757 $73,000
Q4 2021 Feb 11, 2022	BUY	$3.81 - $6.16 $179 - $289	47 Added 0.13%	37,202 $147,000
Q3 2021 Nov 12, 2021	SELL	$3.38 - $5.35 $2,984 - $4,724	-883 Reduced 2.32%	37,155 $179,000
Q2 2021 Aug 13, 2021	BUY	$4.12 - $5.87 $37,302 - $53,146	9,054 Added 31.24%	38,038 $175,000
Q1 2021 May 07, 2021	BUY	$3.45 - $9.09 $17,194 - $45,304	4,984 Added 20.77%	28,984 $170,000
Q4 2020 Feb 12, 2021	SELL	$1.05 - $3.67 $722 - $2,524	-688 Reduced 2.79%	24,000 $82,000
Q3 2020 Nov 04, 2020	SELL	$1.44 - $2.1 $809 - $1,180	-562 Reduced 2.23%	24,688 $36,000
Q2 2020 Aug 12, 2020	BUY	$1.75 - $2.3 $1,191 - $1,566	681 Added 2.77%	25,250 $50,000
Q1 2020 May 04, 2020	SELL	$1.8 - $4.28 $2,554 - $6,073	-1,419 Reduced 5.46%	24,569 $48,000
Q4 2019 Feb 05, 2020	SELL	$3.16 - $5.15 $695 - $1,133	-220 Reduced 0.84%	25,988 $108,000
Q3 2019 Nov 08, 2019	SELL	$1.2 - $6.66 $218 - $1,212	-182 Reduced 0.69%	26,208 $79,000
Q2 2019 Aug 13, 2019	SELL	$5.35 - $7.11 $6,238 - $8,290	-1,166 Reduced 4.23%	26,390 $166,000
Q1 2019 May 06, 2019	SELL	$4.36 - $7.94 $3,893 - $7,090	-893 Reduced 3.14%	27,556 $153,000
Q4 2018 Feb 13, 2019	SELL	$6.15 - $10.51 $1,353 - $2,312	-220 Reduced 0.77%	28,449 $189,000
Q3 2018 Nov 09, 2018	BUY	$10.32 - $13.06 $5,345 - $6,765	518 Added 1.84%	28,669 $306,000
Q2 2018 Aug 08, 2018	BUY	$7.8 - $13.69 $4,719 - $8,282	605 Added 2.2%	28,151 $338,000
Q1 2018 May 07, 2018	SELL	$7.86 - $11.39 $11,648 - $16,879	-1,482 Reduced 5.11%	27,546 $236,000
Q4 2017 Feb 09, 2018	BUY	$8.77 - $12.28 $1,201 - $1,682	137 Added 0.47%	29,028 $287,000
Q3 2017 Nov 09, 2017	BUY	$12.17 - $16.3 $351,603 - $470,923	28,891	28,891 $355,000

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $302M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Lexicon Pharmaceuticals, Inc. Transaction History